Document is current
Any future updates will be listed below
-
Authors
Matsiela, Matome Selina
Naicker, Leeann
Khoza, Thandeka
Mokoena, Nobalanda
-
Funding
Funding for this research was provided by:
National Research Foundation (127779, SRUG2204305498)
Onderstepoort Biological Products (RDV19-002, RDV19-002)
- License Information
-
More Information
Article History
Received: 15 June 2023
Accepted: 7 September 2023
First Online: 3 October 2023
Declarations
:
: The veterinary clinical trial experiment was performed according to the approved protocol by the OBP Animal Ethics Committee (South African Veterinary Council Facility Registration Number: FR1514054) under approval number OBP2019/002 and Department of Agriculture, Land Reform and Rural Development under section 20 of Animal Diseases Act (Act 35 of 1984); approval number 12/11/1/1/(b) MG. The animals included in the study were cleared by the state veterinarian to be free from any communicable diseases affecting ovine. The Langfontein farm where animals are sourced was not under any quarantine at the time of sourcing the sheep as per section 20 of Act 35 of 1984.
: The authors declare the following financial interests which may be considered as potential competing interests: The project was also funded internally from Onderstepoort Biological Products Research budget.
